MI
KWON KIM
Profesor asociado de Ciencias de la Salud
Klinikum der Universität München
Múnich, AlemaniaPublicaciones en colaboración con investigadores/as de Klinikum der Universität München (3)
2024
-
Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells
HemaSphere, Vol. 8, Núm. 7
-
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, Núm. 2, pp. 205-217
2023
-
Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplantation, Vol. 58, Núm. 8, pp. 907-915